KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

医学 指南 重症监护医学 肾脏疾病 批判性评价 狼疮性肾炎 肾小球肾炎 肾病 局灶节段性肾小球硬化 膜性肾病 疾病 免疫学 病理 内科学 替代医学 糖尿病 内分泌学
作者
Brad H. Rovin,Sharon G. Adler,Jonathan Barratt,Frank Bridoux,Kelly A. Burdge,Tak Mao Chan,H. Terence Cook,Fernando C. Fervenza,Keisha Gibson,Richard J. Glassock,David Jayne,Vivekanand Jha,Adrian Liew,Zhihong Liu,Juan M. Mejía‐Vilet,Carla Nester,Jai Radhakrishnan,Elizabeth M. Rave,Heather N. Reich,Pierre Ronco
出处
期刊:Kidney International [Elsevier]
卷期号:100 (4): S1-S276 被引量:1454
标识
DOI:10.1016/j.kint.2021.05.021
摘要

The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 Clinical Practice Guideline for the Management of Glomerular Diseases is an update to the KDIGO 2012 guideline on the topic. The aim is to assist clinicians caring for individuals with glomerular disease, both adults and children. The scope includes various glomerular diseases, including IgA nephropathy (IgAN) and IgA vasculitis (IgAV), membranous nephropathy, nephrotic syndrome in children, minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), infection-related glomerulonephritis (GN), antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, lupus nephritis, and anti-glomerular basement membrane (anti-GBM) antibody GN. In addition, this guideline will be the first to address the subtype of complement-mediated diseases. Each chapter follows the same format providing guidance related to diagnosis, prognosis, treatment, and special situations. The goal of the guideline is to generate a useful resource for clinicians and patients by providing actionable recommendations with valuable infographics based on a rigorous formal systematic literature review. Another aim is to propose research recommendations for areas where there are gaps in knowledge. The guideline targets a broad audience of clinicians treating glomerular disease while being mindful of implications for policy and cost. Development of this guideline update followed an explicit process of evidence review. Treatment approaches and guideline recommendations are based on systematic reviews and evidence synthesis of relevant studies, and appraisal of the quality of the evidence and the strength of recommendations followed the “Grading of Recommendations Assessment, Development, and Evaluation” (GRADE) approach. Limitations of the evidence are discussed, with areas of future research also presented.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
一分发布了新的文献求助10
2秒前
mengyijie发布了新的文献求助10
3秒前
3秒前
科研通AI5应助精明半双采纳,获得10
3秒前
wanci应助lou采纳,获得10
4秒前
4秒前
科研通AI5应助可言飞舞采纳,获得10
5秒前
5秒前
风趣的孤云完成签到,获得积分10
6秒前
6秒前
6秒前
hehe完成签到,获得积分10
7秒前
樊尔风完成签到,获得积分10
7秒前
yii发布了新的文献求助10
7秒前
8秒前
8秒前
9秒前
zz发布了新的文献求助10
9秒前
9秒前
柳行天完成签到 ,获得积分10
10秒前
马吉克wang完成签到,获得积分10
10秒前
10秒前
xiaoqi完成签到,获得积分10
11秒前
宁静致远发布了新的文献求助10
11秒前
jianjiao完成签到,获得积分10
13秒前
外向芫完成签到,获得积分10
13秒前
科研通AI5应助妃莫笑采纳,获得10
14秒前
科研通AI2S应助豆豆糕采纳,获得10
15秒前
肖肖发布了新的文献求助10
15秒前
Star发布了新的文献求助10
15秒前
16秒前
Dandy完成签到,获得积分10
16秒前
16秒前
清弦完成签到,获得积分10
16秒前
17秒前
西瓜完成签到,获得积分10
17秒前
FashionBoy应助科研通管家采纳,获得10
18秒前
wanci应助科研通管家采纳,获得10
18秒前
科研通AI2S应助科研通管家采纳,获得10
18秒前
科研通AI2S应助科研通管家采纳,获得10
18秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Mechanistic Modeling of Gas-Liquid Two-Phase Flow in Pipes 2500
Kelsen’s Legacy: Legal Normativity, International Law and Democracy 1000
Handbook on Inequality and Social Capital 800
Conference Record, IAS Annual Meeting 1977 610
Interest Rate Modeling. Volume 3: Products and Risk Management 600
Interest Rate Modeling. Volume 2: Term Structure Models 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3546381
求助须知:如何正确求助?哪些是违规求助? 3123456
关于积分的说明 9355545
捐赠科研通 2822036
什么是DOI,文献DOI怎么找? 1551259
邀请新用户注册赠送积分活动 723264
科研通“疑难数据库(出版商)”最低求助积分说明 713688